Venture financing & private placement round-up: 17-23 November
This article was originally published in Scrip
Executive Summary
The week's biggest venture financing as reported by Medtrack was Applied Genetic Technologies' $37.5 million series B round. The funding will allow it to continue its Phase II program in Alpha-1 Antitrypsin Deficiency and begin developmnet of treatments for two orphan ophthalmology indications, achromatopsia and X-Linked Retinoschisis.